catechol-3,6-bis(methyleneiminodiacetic acid) has been researched along with uranium in 6 studies
| Studies (catechol-3,6-bis(methyleneiminodiacetic acid)) | Trials (catechol-3,6-bis(methyleneiminodiacetic acid)) | Recent Studies (post-2010) (catechol-3,6-bis(methyleneiminodiacetic acid)) | Studies (uranium) | Trials (uranium) | Recent Studies (post-2010) (uranium) |
|---|---|---|---|---|---|
| 12 | 0 | 3 | 7,347 | 14 | 2,821 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZJ; Liang, YY; Tao, ZQ; Xie, YY; Xu, XH; Yan, XM; Zhang, JS | 1 |
| Fukuda, S; Iida, H; Ikeda, M; Xie, Y; Yan, X | 1 |
| Fukuda, S | 1 |
| Fukuda, S; Ikeda, M; Nakamura, M; Xie, Y; Yan, X | 3 |
1 review(s) available for catechol-3,6-bis(methyleneiminodiacetic acid) and uranium
| Article | Year |
|---|---|
Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
Topics: Animals; Aza Compounds; Catechols; Chelating Agents; Deferiprone; Diphosphonates; Emergency Medicine; Humans; Iron Chelating Agents; Pentetic Acid; Plutonium; Pyridones; Radiation Injuries; Uranium | 2005 |
5 other study(ies) available for catechol-3,6-bis(methyleneiminodiacetic acid) and uranium
| Article | Year |
|---|---|
[Detoxication and mobilization of uranium by catecholamic acid].
Topics: Animals; Catechols; Chelating Agents; Inactivation, Metabolic; Male; Mice; Rats; Uranium; Uranyl Nitrate | 1987 |
Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats.
Topics: Animals; Catechols; Chelating Agents; Chelation Therapy; Diphosphonates; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Foreign Bodies; Injections, Intramuscular; Men; Metabolic Clearance Rate; Organ Specificity; Radiation Injuries; Radiation Protection; Rats; Rats, Wistar; Survival; Tissue Distribution; Treatment Outcome; Uranium; Wounds, Penetrating | 2005 |
Effects of pH on du intake and removal by CBMIDA and EHBP.
Topics: Animals; Catechols; Chelating Agents; Diphosphonates; Dose-Response Relationship, Radiation; Feces; Hydrogen-Ion Concentration; Injections, Intraperitoneal; Male; Metabolic Clearance Rate; Organ Specificity; Radiation-Protective Agents; Rats; Rats, Wistar; Tissue Distribution; Uranium | 2007 |
Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium.
Topics: Administration, Oral; Animals; Catechols; Chelating Agents; Infusions, Parenteral; Male; Radiation Protection; Rats; Rats, Wistar; Uranium | 2009 |
Acute toxicity of subcutaneously administered depleted uranium and the effects of CBMIDA in the simulated wounds of rats.
Topics: Animals; Catechols; Chelating Agents; Hydrogen-Ion Concentration; Injections, Subcutaneous; Kidney; Liver; Male; Rats; Rats, Wistar; Uranium; Wounds and Injuries | 2009 |